POST Online Media Lite Edition


Bionest appoints Sean X. Hu as managing director for North America

Staff writer |
New York, USA - October 18, 2010, New York, USA - Bionest Partners, a provider of services to life sciences companies, announce that Sean Xinghua Hu has been appointed managing director for North America, and head of Bionest USA.

Mr. Hu brings more than six years of life science industry management consulting experience from IMS Management Consulting/SDG Life Sciences and AT Kearney. He was an early participant of the Human Genome Project and later involved in the International HapMap Project, both considered key scientific foundation of the personalized medicine field.

Trained and experienced in business as well as sciences, Mr. Hu brings both commercial and R&D perspectives to clients and has consulted extensively on broad personalized medicine strategy related issues. He was a representative on the FDA personalized medicine initiative consortium.

Earlier in his career and as part of his more than 17 years of experience in life science industries and academia, Mr. Hu worked for a number of life science companies of various sizes and industry segments.

Mr. Hu served as a business development professional at Illumina, a world leading genetic analysis/personalized medicine-enabling tool provider, at Bristol-Myers Squibb, a major pharma, in Sales and Marketing Services capacity, and at CuraGen, a genomic biopharma as a senior R&D scientist and operations manager.


John Weisel joins ZRG
Greene County Bancorp appoints Paul Slutzky as chairman
Indivior promotes Ryan Preblick to permanent CFO
Thermo Fisher Scientific appoints R. Alexandra Keith to board
Conformal Medical appoints George Fazio to board

What to read next

Diebold names Octavio Marquez to lead operations in Americas
ConAgra Foods appoints Sean Connolly as CEO
Shutl appoints two to management team